Biologics in Myelodysplastic Syndrome-related Systemic Inflammatory and Autoimmune Diseases: French Multicenter Retrospective Study of 29 Patients
Conclusion This nationwide study demonstrates the efficacy of steroids for SIAD-associated MDSs but a high frequency of steroid dependence. The response to biologics seems low, but rituximab and azacytidine seem promising.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research
More News: Actemra | Allergy & Immunology | Anemia | Arthritis | Autoimmune Disease | Corticosteroid Therapy | France Health | Myelodysplastic Syndrome | Polychondritis | Rheumatology | Rituxan | Study | Vasculitis